<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> is a major risk factor for <z:mp ids='MP_0001914'>hemorrhage</z:mp>, but platelet function and <z:mp ids='MP_0001914'>bleeding</z:mp> risk at <z:hpo ids='HP_0001873'>low platelet counts</z:hpo> are poorly understood, because of the limitations of platelet function testing at very <z:hpo ids='HP_0001873'>low platelet counts</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVES: To examine and compare platelet function in severely thrombocytopenic patients with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) or <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with that in patients with <z:hpo ids='HP_0001973'>immune thrombocytopenia</z:hpo> (<z:chebi fb="0" ids="16039">ITP</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Whole blood flow cytometric measurement of platelet activation and platelet reactivity to <z:chebi fb="4" ids="48705">agonists</z:chebi> was correlated with the immature platelet fraction (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e>) and <z:mp ids='MP_0001914'>bleeding</z:mp> symptoms </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Patients with <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e> had smaller platelets, lower <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> and substantially lower platelet surface expression of activated <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> (GP)IIb-IIIa and GPIb, both with and without addition of ex vivo <z:chebi fb="13" ids="16761">ADP</z:chebi> or thrombin receptor-activating <z:chebi fb="7" ids="16670">peptide</z:chebi>, than patients with <z:chebi fb="0" ids="16039">ITP</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>In both <z:chebi fb="0" ids="16039">ITP</z:chebi> and <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e> patients, increased platelet surface GPIb on circulating platelets and expression of activated GPIIb-IIIa and GPIb on ex vivo activated platelets correlated with a higher <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Whereas platelet reactivity was higher for <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e> patients with <z:mp ids='MP_0001914'>bleeding</z:mp> than for those with no <z:mp ids='MP_0001914'>bleeding</z:mp>, platelet reactivity was lower for <z:chebi fb="0" ids="16039">ITP</z:chebi> patients with <z:mp ids='MP_0001914'>bleeding</z:mp> than for those with no <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e> patients have lower in vivo platelet activation and ex vivo platelet reactivity than patients with <z:chebi fb="0" ids="16039">ITP</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>The proportion of newly produced platelets correlates with the expression of platelet surface markers of activation </plain></SENT>
<SENT sid="8" pm="."><plain>These differences might contribute to differences in <z:hpo ids='HP_0001892'>bleeding tendency</z:hpo> between <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e> and <z:chebi fb="0" ids="16039">ITP</z:chebi> patients </plain></SENT>
<SENT sid="9" pm="."><plain>This study is the first to define differences in platelet function between <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e> patients and <z:chebi fb="0" ids="16039">ITP</z:chebi> patients with equivalent degrees of <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
</text></document>